MRKR CIK: 1094038

Marker Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.3
FY22:
−27.0
FY23:
−16.4
FY24:
−10.9
FY25:
−12.0
Change from FY21 to FY23
millions USD
FY21:
−3.13
FY22:
−4.95
FY23:
18.7
FY24:
–
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
52.6
FY22:
0.20
FY23:
1.11
FY24:
15.0
FY25:
9.86
millions USD
FY21:
43.5
FY22:
11.8
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR